Frazier Lifesciences Acquisition Corporation

FLAC

KYG3710A1058

Frazier Lifesciences Acquisition Corp. announced that it has received $5.01 million in funding from Frazier Lifesciences Sponsor LLC

December 10, 2020

On December 11, 2020, Frazier Lifesciences Acquisition Corp. closed the transaction. The company has issued 501,000 units for gross proceeds of $5,010,000 in the transaction.

Latest news about Frazier Lifesciences Acquisition Corporation

Frazier Lifesciences Acquisition Corporation Announces Executive Changes	23/11/22	CI
Frazier Lifesciences Acquisition Corporation(NasdaqCM:FLAC) dropped from NASDAQ Composite Index	22/11/22	CI
NewAmsterdam Pharma B.V. completed the acquisition of Frazier Lifesciences Acquisition Corporation from a group of shareholders in a reverse merger transaction.	21/11/22	CI
Frazier Lifesciences Shareholders Approve Merger With NewAmsterdam Pharma Holding	15/11/22	MT
Frazier Lifesciences Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/11/22	CI
Frazier Lifesciences Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
NewAmsterdam Pharma to Go Public in Deal With Frazier Lifesciences SPAC	25/07/22	MT
NewAmsterdam Pharma B.V. entered into a definitive business combination agreement to acquire Frazier Lifesciences Acquisition Corporation from a group of shareholders for approximately $490 million.	24/07/22	CI
Frazier Lifesciences Acquisition Negotiates Business Combination With NewAmsterdam Pharma	20/07/22	MT
Frazier Lifesciences Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	12/05/22	CI
Frazier Lifesciences Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	25/03/22	CI
Frazier Lifesciences Acquisition Corporation Auditor Raises 'Going Concern' Doubt	24/03/22	CI
Certain Class B Ordinary Shares of Frazier Lifesciences Acquisition Corporation are subject to a Lock-Up Agreement Ending on 6-JUN-2021.	05/06/21	CI
Frazier Lifesciences Acquisition Corp.(NasdaqCM:FLAC) added to NASDAQ Composite Index	09/02/21	CI
Frazier Lifesciences Acquisition Corp. announced that it has received $5.01 million in funding from Frazier Lifesciences Sponsor LLC	10/12/20	CI
Frazier Lifesciences Acquisition Corporation has completed an IPO in the amount of $120 million.	08/12/20	CI
Frazier Lifesciences Acquisition Corporation has filed an IPO in the amount of $100 million.	20/11/20	CI
Frazier Lifesciences Acquisition Corp. announced that it expects to receive $4.25 million in funding from Frazier Lifesciences Sponsor LLC	14/10/20	CI

Chart Frazier Lifesciences Acquisition Corporation

Duration

Period

Chart Frazier Lifesciences Acquisition Corporation

More charts

Frazier Lifesciences Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. It intends to identify opportunities in the biotechnology sector. It has conducted no operations and has generated no revenues.

Sector

More about the company